Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hong Kong issues revised marketing practices code

This article was originally published in Scrip

Executive Summary

The Hong Kong Association of the Pharmaceutical Industry (HKAPI) has revised its code of pharmaceutical marketing practice, to ensure healthcare professionals receive accurate, fair and scientific-based information about medicines from pharmaceutical companies. The revisions, which became effective in April this year, align Hong Kong with the global standards set by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), which released its most recent edition of its code last January (Scrip Online, January 11th, 2007) outlining clearer guidelines for conduct, including limiting sponsorship and prohibiting the offer of cash and personal gifts. The revised Hong Kong code of practice, the 13th edition of the guidelines, became effective in April this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC030968

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel